Determinants of mortality in systemic sclerosis: a focused review

Dilli Ram Poudel, Divya Jayakumar, Abhijeet Danve, Shiv Tej Sehra, Chris T. Derk

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations


Scleroderma (systemic sclerosis) is an autoimmune rheumatic disorder that is characterized by fibrosis, vascular dysfunction, and autoantibody production that involves most visceral organs. It is characterized by a high morbidity and mortality rate, mainly due to disease-related complications. Epidemiological data describing mortality and survival in this population have been based on both population and observational studies. Multiple clinical and non-clinical factors have been found to predict higher likelihood of death among thepatients. Here, we do an extensive review of the available literature, utilizing the PubMed database, to describe scleroderma and non-scleroderma related determinants of mortality in this population. We found that even though the mortality among the general population has declined, scleroderma continues to carry a very high morbidity and mortality rate, however we have made some slow progress in improving the mortality among scleroderma patients over the last few decades.

Original languageEnglish
Pages (from-to)1847-1858
Number of pages12
JournalRheumatology International
Issue number10
StatePublished - Oct 1 2018


  • Mortality
  • Predictor
  • Review
  • Scleroderma
  • Survival
  • Systemic sclerosis


Dive into the research topics of 'Determinants of mortality in systemic sclerosis: a focused review'. Together they form a unique fingerprint.

Cite this